With this AsiC (EpCAM-siPKCι aptamer), we achieved efficient knockdown of PKCι in ovarian cancer cells and detected dose-dependent apoptosis only in PRKCI-amplified ovarian cancer cells (Fig. 5). The gene discussed is PRKCI; the disease is ovarian carcinoma.